L1 Capital Global Opportunities Master Fund, Ltd. 13D and 13G filings for ENDRA Life Sciences Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 5:04 pm Purchase | 2024-12-31 | 13G | ENDRA Life Sciences Inc. NDRA | L1 Capital Global Opportunities Master Fund, Ltd. | 35,589 6.220% | 31,062 (+686.21%) | Filing |
| 2024-06-14 08:00 am Purchase | 2024-06-04 | 13G | ENDRA Life Sciences Inc. NDRA | L1 Capital Global Opportunities Master Fund, Ltd. | 4,527 9.990% | 4,527 (New Position) | Filing |